Risk of multiple sclerosis during tumour necrosis factor inhibitor treatment for arthritis: a population-based study from DANBIO and the Danish Multiple Sclerosis Registry

Registers of multiple sclerosis in Denmark

(2015) N. Koch-Henriksen et al.   ACTA NEUROLOGICA SCANDINAVICA

Role of the innate and adaptive immune responses in the course of multiple sclerosis

(2015) Bernhard Hemmer et al.   LANCET NEUROLOGY

Gender and autoimmune comorbidity in multiple sclerosis

(2014) Melinda Magyari et al.   Multiple Sclerosis Journal

Demyelinizing neurological disease after treatment with tumor necrosis factor alpha-inhibiting agents in a rheumatological outpatient clinic: description of six cases

(2013) Ali Theibich et al.   CLINICAL RHEUMATOLOGY

Demyelination during tumour necrosis factor antagonist therapy for psoriasis: a case report and review of the literature

(2012) SATVEER K. Mahil et al.   JOURNAL OF DERMATOLOGICAL TREATMENT

Demyelinating Disease in Patients Treated with TNF Antagonists in Rheumatology: Data from BIOBADASER, a Pharmacovigilance Database, and a Systematic Review

(2011) María Cruz Fernández-Espartero et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

DANBIO--powerful research database and electronic patient record

(2010) M. L. Hetland   RHEUMATOLOGY

Are Individuals With an Autoimmune Disease at Higher Risk of a Second Autoimmune Disorder?

(2009) E. C. Somers et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY